United States · FDA National Drug Code directory
Bronchial Cough Therapy
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17312-018_4604e0a2-5b75-5e33-e063-6294a90a6601
- Product NDC
- 17312-018
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- ANTIMONY POTASSIUM TARTRATE - PROTORTONIA CACTI - DROSERA ROTUNDIFOLIA - ECHINACEA, UNSPECIFIED - CALCIUM SULFIDE - HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED - SPONGIA OFFICINALIS SKELETON, ROASTED -
- Labeler
- TRP Company
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20111201
- Source listing expiry
- 20261231
Source-listed ingredients
- SPONGIA OFFICINALIS SKELETON, ROASTED — 6 [hp_C]/1
- ANTIMONY POTASSIUM TARTRATE — 6 [hp_C]/1
- PROTORTONIA CACTI — 6 [hp_C]/1
- DROSERA ROTUNDIFOLIA — 6 [hp_C]/1
- ECHINACEA, UNSPECIFIED — 6 [hp_C]/1
- CALCIUM SULFIDE — 6 [hp_C]/1
- HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED — 18 [hp_C]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 PACKAGE (17312-018-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE · 17312-018-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →